What is NDC 0173-0922?

0173-0922 is the product NDC for Blujepa (gepotidacin), Gepotidacin mesylate 750 mg/1 tablet, film coated, listed with the FDA by GlaxoSmithKline LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

GlaxoSmithKline LLC, NDC labeler code 0173. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Blujepa?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Blujepa NDC 0173-0922 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0173-0922Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00173-0922Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0173-0922-38	00173092238	8 TABLET, FILM COATED in 1 BOTTLE (0173-0922-38)Marketed from Dec 11, 2025
0173-0922-45	00173092245	20 TABLET, FILM COATED in 1 BOTTLE (0173-0922-45)Marketed from Mar 25, 2025

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Blujepa
Generic name (nonproprietary): gepotidacin
Active ingredients: Gepotidacin mesylate — 750 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: GlaxoSmithKline LLCNDC labeler code 0173
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 218230
Marketing start: Mar 25, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Cholinesterase Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)Topoisomerase 2 Inhibitors (Mechanism)Topoisomerase 4 Inhibitors (Mechanism)
Identifiers: Product ID 0173-0922_1cb00eb0-9123-4532-b49e-55b9265daf9eSPL ID 1cb00eb0-9123-4532-b49e-55b9265daf9eSPL set ID 80b57cfe-7819-4d95-a57d-014af42f118dRxCUI 2709218, 2709224UNII 5P7X0H2O6BUPC 0301730922458
Pharmacologic class: Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400173092238 followed by a unit qualifier and the quantity

Package 00173-0922-38. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 10, 2026.

Indications (excerpt from the label)

BLUJEPA is a triazaacenaphthylene bacterial type II topoisomerase inhibitor indicated for the treatment of the following infections caused by susceptible microorganisms: • Uncomplicated urinary tract infections (uUTI) in female adult and pediatric patients 12 years of age and older weighing at least 40 kilograms (kg). ( 1.1 ) • Uncomplicated urogenital gonorrhea in adult and pediatric patients 12 years of age and older weighing at least 45 kilograms who have limited or no alternative treatment options. Approval of this indication is based on limited clinical safety data for this indication. ( 1.2 , 6.1 ) Usage to Reduce Development of Drug-Resistant Bacteria To reduce the development of drug…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0173-0922

What is NDC 0173-0922?: 0173-0922 is the product NDC for Blujepa (gepotidacin), Gepotidacin mesylate 750 mg/1 tablet, film coated, listed with the FDA by GlaxoSmithKline LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Blujepa (Gepotidacin).
What is the active ingredient?: Gepotidacin mesylate.
Who is the labeler?: GlaxoSmithKline LLC, NDC labeler code 0173. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Blujepa?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Blujepa (Gepotidacin) NDC 0173-0922